ADXN
Price
$2.89
Change
-$0.14 (-4.62%)
Updated
Oct 22, 04:37 PM (EDT)
Capitalization
3.84M
42 days until earnings call
Intraday BUY SELL Signals
ANVS
Price
$1.00
Change
+$0.01 (+1.01%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
42.39M
20 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ADXN vs ANVS

ADXN vs ANVS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ADXN vs. ANVS commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADXN is a Hold and ANVS is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ADXN with price predictions
Oct 21, 2026

Momentum Indicator for ADXN turns negative, indicating new downward trend

ADXN saw its Momentum Indicator move below the 0 level on October 16, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 134 similar instances where the indicator turned negative. In 122 of the 134 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADXN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for ADXN entered a downward trend on October 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ADXN's RSI Indicator exited the oversold zone, 22 of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 67 of 78 cases where ADXN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.

The Moving Average Convergence Divergence (MACD) for ADXN just turned positive on September 16, 2026. Looking at past instances where ADXN's MACD turned positive, the stock continued to rise in 37 of 49 cases over the following month. The odds of a continued upward trend are 76%.

Following a +3.30% 3-day Advance, the price is estimated to grow further. Considering data from situations where ADXN advanced for three days, in 158 of 200 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

ADXN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.010) is normal, around the industry mean (2.988). P/E Ratio (-0.421) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (86.207) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 86 (best 1 - 100 worst), indicating slightly worse than average price growth. ADXN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ADXN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for ANVS with price predictions
Oct 21, 2026

ANVS sees MACD Histogram crosses below signal line

ANVS saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 14, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 49 instances where the indicator turned negative. In 45 of the 49 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ANVS as a result. In 70 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ANVS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for ANVS entered a downward trend on September 25, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ANVS's RSI Oscillator exited the oversold zone, 26 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +3.46% 3-day Advance, the price is estimated to grow further. Considering data from situations where ANVS advanced for three days, in 191 of 241 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 11 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 12 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-9.963) is normal, around the industry mean (2.988). P/E Ratio (-0.568) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 85 (best 1 - 100 worst), indicating slightly worse than average price growth. ANVS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ANVS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
ADXN vs ANVS: Fundamental Ratings
ADXN
ANVS
OUTLOOK RATING
1..100
6180
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
12
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
8685
P/E GROWTH RATING
1..100
1011
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ANVS's Valuation (12) in the null industry is somewhat better than the same rating for ADXN (68). This means that ANVS’s stock grew somewhat faster than ADXN’s over the last 12 months.

ANVS's Profit vs Risk Rating (100) in the null industry is in the same range as ADXN (100). This means that ANVS’s stock grew similarly to ADXN’s over the last 12 months.

ADXN's SMR Rating (99) in the null industry is in the same range as ANVS (100). This means that ADXN’s stock grew similarly to ANVS’s over the last 12 months.

ANVS's Price Growth Rating (85) in the null industry is in the same range as ADXN (86). This means that ANVS’s stock grew similarly to ADXN’s over the last 12 months.

ADXN's P/E Growth Rating (10) in the null industry is in the same range as ANVS (11). This means that ADXN’s stock grew similarly to ANVS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ADXNANVS
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 7 days ago
76%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 9 days ago
79%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (ADXN: $3.03 vs. ANVS: $0.99)
Brand notoriety: ADXN and ANVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADXN: 2% vs. ANVS: 56%
Market capitalization -- ADXN: $3.84M vs. ANVS: $42.39M
ADXN [@Biotechnology] is valued at $3.84M. ANVS’s [@Biotechnology] market capitalization is $42.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $132.95B. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADXN’s FA Score shows that 1 FA rating(s) are green while ANVS’s FA Score has 2 green FA rating(s).

  • ADXN’s FA Score: 1 green, 4 red.
  • ANVS’s FA Score: 2 green, 3 red.
According to our system of comparison, ANVS is a better buy in the long-term than ADXN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADXN’s TA Score shows that 5 TA indicator(s) are bullish while ANVS’s TA Score has 3 bullish TA indicator(s).

  • ADXN’s TA Score: 5 bullish, 3 bearish.
  • ANVS’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ADXN is a better buy in the short-term than ANVS.

Price Growth

ADXN (@Biotechnology) experienced а -3.19% price change this week, while ANVS (@Biotechnology) price change was -2.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.

Reported Earning Dates

ADXN is expected to report earnings on Dec 03, 2026.

ANVS is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (-1.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ADXN
Daily Signal:
Gain/Loss:
ANVS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MYGN5.570.03
+0.54%
Myriad Genetics
CSL340.100.31
+0.09%
Carlisle Companies
WDFC192.56-8.85
-4.39%
WD-40 Company
AEMD5.07-0.24
-4.52%
Aethlon Medical Inc
TNYA0.39-0.02
-4.83%
Tenaya Therapeutics